Under the Nose Face Mask to Prevent Facial Pressure Ulcers During NIV for Acute Hypercapnic Respiratory Failure (AHRF)
Launched by CENTRE HOSPITALIER ARRAS · Sep 24, 2019
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute hypercapnic respiratory failure
- • Initiation of NIV
- • Estimated cumulative time of NIV upper than 12 hours for the first 48 hours of hospitalization
- Exclusion Criteria:
- • Contraindication for NIV (respiratory arrest, impossibility to fit the mask)
- • Intubated patient
- • Patient with a tracheostomy
- • Post-extubation respiratory failure
- • Patient exhibiting facial ulcers or skin lesions located at the insertion points of the mask before its hospitalization
- • Person declining NIV
- • Pregnancy
- • Dying person
About Centre Hospitalier Arras
Centre Hospitalier Arras is a leading healthcare institution dedicated to advancing medical research and enhancing patient care through innovative clinical trials. With a strong commitment to ethical practices and patient safety, the hospital collaborates with multidisciplinary teams of healthcare professionals to conduct rigorous studies across various therapeutic areas. By leveraging its state-of-the-art facilities and expertise, Centre Hospitalier Arras aims to contribute valuable insights to the medical community and improve treatment outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lens, , France
Arras, , France
Patients applied
Trial Officials
Malcolm LEMYZE, MD
Principal Investigator
Centre Hospitalier Arras
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials